AGILENT TECHNOLOGIES INC (A) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:A • US00846U1016

130.525 USD
-2.45 (-1.85%)
Last: Feb 5, 2026, 10:50 AM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to A. A was compared to 57 industry peers in the Life Sciences Tools & Services industry. A gets an excellent profitability rating and is at the same time showing great financial health properties. A is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • A had positive earnings in the past year.
  • In the past year A had a positive cash flow from operations.
  • In the past 5 years A has always been profitable.
  • Each year in the past 5 years A had a positive operating cash flow.
A Yearly Net Income VS EBIT VS OCF VS FCFA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • The Return On Assets of A (10.24%) is better than 89.47% of its industry peers.
  • A's Return On Equity of 19.33% is amongst the best of the industry. A outperforms 89.47% of its industry peers.
  • The Return On Invested Capital of A (13.20%) is better than 87.72% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for A is in line with the industry average of 13.78%.
Industry RankSector Rank
ROA 10.24%
ROE 19.33%
ROIC 13.2%
ROA(3y)10.88%
ROA(5y)11.17%
ROE(3y)20.8%
ROE(5y)21.7%
ROIC(3y)13.47%
ROIC(5y)13.97%
A Yearly ROA, ROE, ROICA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • With an excellent Profit Margin value of 18.75%, A belongs to the best of the industry, outperforming 92.98% of the companies in the same industry.
  • In the last couple of years the Profit Margin of A has grown nicely.
  • A has a better Operating Margin (22.47%) than 92.98% of its industry peers.
  • A's Operating Margin has improved in the last couple of years.
  • A has a better Gross Margin (52.73%) than 64.91% of its industry peers.
  • In the last couple of years the Gross Margin of A has remained more or less at the same level.
Industry RankSector Rank
OM 22.47%
PM (TTM) 18.75%
GM 52.73%
OM growth 3Y-1.66%
OM growth 5Y6.93%
PM growth 3Y0.8%
PM growth 5Y6.85%
GM growth 3Y-1%
GM growth 5Y-0.15%
A Yearly Profit, Operating, Gross MarginsA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), A is creating some value.
  • A has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for A has been reduced compared to 5 years ago.
  • The debt/assets ratio for A has been reduced compared to a year ago.
A Yearly Shares OutstandingA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
A Yearly Total Debt VS Total AssetsA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 5.09 indicates that A is not in any danger for bankruptcy at the moment.
  • A has a Altman-Z score of 5.09. This is amongst the best in the industry. A outperforms 84.21% of its industry peers.
  • A has a debt to FCF ratio of 2.91. This is a good value and a sign of high solvency as A would need 2.91 years to pay back of all of its debts.
  • A has a Debt to FCF ratio of 2.91. This is amongst the best in the industry. A outperforms 82.46% of its industry peers.
  • A has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.45, A is doing worse than 64.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.91
Altman-Z 5.09
ROIC/WACC1.22
WACC10.85%
A Yearly LT Debt VS Equity VS FCFA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • A has a Current Ratio of 1.96. This is a normal value and indicates that A is financially healthy and should not expect problems in meeting its short term obligations.
  • A's Current ratio of 1.96 is in line compared to the rest of the industry. A outperforms 40.35% of its industry peers.
  • A Quick Ratio of 1.52 indicates that A should not have too much problems paying its short term obligations.
  • The Quick ratio of A (1.52) is worse than 61.40% of its industry peers.
  • The current and quick ratio evaluation for A is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.52
A Yearly Current Assets VS Current LiabilitesA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

4

3. Growth

3.1 Past

  • A shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.48%.
  • A shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.21% yearly.
  • A shows a small growth in Revenue. In the last year, the Revenue has grown by 6.73%.
  • Measured over the past years, A shows a small growth in Revenue. The Revenue has been growing by 5.41% on average per year.
EPS 1Y (TTM)5.48%
EPS 3Y2.31%
EPS 5Y11.21%
EPS Q2Q%8.9%
Revenue 1Y (TTM)6.73%
Revenue growth 3Y0.48%
Revenue growth 5Y5.41%
Sales Q2Q%9.41%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.21% on average over the next years. This is quite good.
  • Based on estimates for the next years, A will show a small growth in Revenue. The Revenue will grow by 5.84% on average per year.
EPS Next Y8.47%
EPS Next 2Y9.31%
EPS Next 3Y10.11%
EPS Next 5Y9.21%
Revenue Next Year6.38%
Revenue Next 2Y6.31%
Revenue Next 3Y6.39%
Revenue Next 5Y5.84%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
A Yearly Revenue VS EstimatesA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
A Yearly EPS VS EstimatesA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

  • A is valuated rather expensively with a Price/Earnings ratio of 23.39.
  • 77.19% of the companies in the same industry are more expensive than A, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 28.25, A is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 21.57, the valuation of A can be described as rather expensive.
  • A's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. A is cheaper than 78.95% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.50, A is valued a bit cheaper.
Industry RankSector Rank
PE 23.39
Fwd PE 21.57
A Price Earnings VS Forward Price EarningsA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, A is valued a bit cheaper than 70.18% of the companies in the same industry.
  • 71.93% of the companies in the same industry are more expensive than A, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 32.12
EV/EBITDA 21.24
A Per share dataA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.76
PEG (5Y)2.09
EPS Next 2Y9.31%
EPS Next 3Y10.11%

5

5. Dividend

5.1 Amount

  • A has a yearly dividend return of 0.77%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.09, A pays a better dividend. On top of this A pays more dividend than 100.00% of the companies listed in the same industry.
  • With a Dividend Yield of 0.77, A pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.77%

5.2 History

  • The dividend of A is nicely growing with an annual growth rate of 6.57%!
  • A has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of A decreased recently.
Dividend Growth(5Y)6.57%
Div Incr Years1
Div Non Decr Years1
A Yearly Dividends per shareA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • A pays out 21.64% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of A is growing, but earnings are growing more, so the dividend growth is sustainable.
DP21.64%
EPS Next 2Y9.31%
EPS Next 3Y10.11%
A Yearly Income VS Free CF VS DividendA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B
A Dividend Payout.A Dividend Payout, showing the Payout Ratio.A Dividend Payout.PayoutRetained Earnings

AGILENT TECHNOLOGIES INC

NYSE:A (2/5/2026, 10:50:09 AM)

130.525

-2.45 (-1.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-24
Earnings (Next)02-24
Inst Owners92%
Inst Owner Change-1.86%
Ins Owners0.16%
Ins Owner Change3.03%
Market Cap37.00B
Revenue(TTM)6.95B
Net Income(TTM)1.30B
Analysts77.86
Price Target170.7 (30.78%)
Short Float %1.41%
Short Ratio1.92
Dividend
Industry RankSector Rank
Dividend Yield 0.77%
Yearly Dividend0.99
Dividend Growth(5Y)6.57%
DP21.64%
Div Incr Years1
Div Non Decr Years1
Ex-Date01-06
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.62%
Min EPS beat(2)-1.64%
Max EPS beat(2)-1.6%
EPS beat(4)2
Avg EPS beat(4)-0.13%
Min EPS beat(4)-1.64%
Max EPS beat(4)1.56%
EPS beat(8)6
Avg EPS beat(8)0.96%
EPS beat(12)9
Avg EPS beat(12)1.07%
EPS beat(16)12
Avg EPS beat(16)1.9%
Revenue beat(2)1
Avg Revenue beat(2)0.93%
Min Revenue beat(2)-0.43%
Max Revenue beat(2)2.3%
Revenue beat(4)2
Avg Revenue beat(4)0.29%
Min Revenue beat(4)-1.23%
Max Revenue beat(4)2.3%
Revenue beat(8)3
Avg Revenue beat(8)0%
Revenue beat(12)5
Avg Revenue beat(12)-0.01%
Revenue beat(16)7
Avg Revenue beat(16)0.18%
PT rev (1m)0.02%
PT rev (3m)21.37%
EPS NQ rev (1m)-0.05%
EPS NQ rev (3m)-2.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.32%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)1.6%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.86%
Valuation
Industry RankSector Rank
PE 23.39
Fwd PE 21.57
P/S 5.33
P/FCF 32.12
P/OCF 23.74
P/B 5.49
P/tB 20.3
EV/EBITDA 21.24
EPS(TTM)5.58
EY4.28%
EPS(NY)6.05
Fwd EY4.64%
FCF(TTM)4.06
FCFY3.11%
OCF(TTM)5.5
OCFY4.21%
SpS24.51
BVpS23.78
TBVpS6.43
PEG (NY)2.76
PEG (5Y)2.09
Graham Number54.64
Profitability
Industry RankSector Rank
ROA 10.24%
ROE 19.33%
ROCE 15.04%
ROIC 13.2%
ROICexc 15.95%
ROICexgc 37.3%
OM 22.47%
PM (TTM) 18.75%
GM 52.73%
FCFM 16.58%
ROA(3y)10.88%
ROA(5y)11.17%
ROE(3y)20.8%
ROE(5y)21.7%
ROIC(3y)13.47%
ROIC(5y)13.97%
ROICexc(3y)16.03%
ROICexc(5y)16.51%
ROICexgc(3y)38.11%
ROICexgc(5y)42.31%
ROCE(3y)15.36%
ROCE(5y)15.95%
ROICexgc growth 3Y-8.87%
ROICexgc growth 5Y3.18%
ROICexc growth 3Y-4.92%
ROICexc growth 5Y7.55%
OM growth 3Y-1.66%
OM growth 5Y6.93%
PM growth 3Y0.8%
PM growth 5Y6.85%
GM growth 3Y-1%
GM growth 5Y-0.15%
F-Score5
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.91
Debt/EBITDA 1.65
Cap/Depr 141.32%
Cap/Sales 5.86%
Interest Coverage 15.46
Cash Conversion 84.32%
Profit Quality 88.41%
Current Ratio 1.96
Quick Ratio 1.52
Altman-Z 5.09
F-Score5
WACC10.85%
ROIC/WACC1.22
Cap/Depr(3y)132.79%
Cap/Depr(5y)109.81%
Cap/Sales(3y)5.34%
Cap/Sales(5y)4.65%
Profit Quality(3y)104.6%
Profit Quality(5y)100.47%
High Growth Momentum
Growth
EPS 1Y (TTM)5.48%
EPS 3Y2.31%
EPS 5Y11.21%
EPS Q2Q%8.9%
EPS Next Y8.47%
EPS Next 2Y9.31%
EPS Next 3Y10.11%
EPS Next 5Y9.21%
Revenue 1Y (TTM)6.73%
Revenue growth 3Y0.48%
Revenue growth 5Y5.41%
Sales Q2Q%9.41%
Revenue Next Year6.38%
Revenue Next 2Y6.31%
Revenue Next 3Y6.39%
Revenue Next 5Y5.84%
EBIT growth 1Y-0.19%
EBIT growth 3Y-1.19%
EBIT growth 5Y12.72%
EBIT Next Year27.4%
EBIT Next 3Y14.45%
EBIT Next 5Y11.39%
FCF growth 1Y-16.1%
FCF growth 3Y4.11%
FCF growth 5Y7.51%
OCF growth 1Y-10.97%
OCF growth 3Y5.92%
OCF growth 5Y11.1%

AGILENT TECHNOLOGIES INC / A FAQ

Can you provide the ChartMill fundamental rating for AGILENT TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 6 / 10 to A.


Can you provide the valuation status for AGILENT TECHNOLOGIES INC?

ChartMill assigns a valuation rating of 4 / 10 to AGILENT TECHNOLOGIES INC (A). This can be considered as Fairly Valued.


Can you provide the profitability details for AGILENT TECHNOLOGIES INC?

AGILENT TECHNOLOGIES INC (A) has a profitability rating of 8 / 10.


What is the valuation of AGILENT TECHNOLOGIES INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for AGILENT TECHNOLOGIES INC (A) is 23.39 and the Price/Book (PB) ratio is 5.49.


Can you provide the dividend sustainability for A stock?

The dividend rating of AGILENT TECHNOLOGIES INC (A) is 5 / 10 and the dividend payout ratio is 21.64%.